These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

112 related items for PubMed ID: 318732

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Hepatitis B virus infection in allogeneic bone marrow transplantation.
    Ustün C, Koç H, Karayalcin S, Akyol G, Gürman G, Ilhan O, Akan H, Ozcan M, Arslan O, Konuk N, Uysal A, Beksaç M.
    Bone Marrow Transplant; 1997 Aug; 20(4):289-96. PubMed ID: 9285543
    [Abstract] [Full Text] [Related]

  • 3. The effect of HBsAg-positivity of kidney donors on long-term patient and graft outcome.
    Berber I, Aydin C, Yigit B, Turkmen F, Titiz IM, Altaca G.
    Transplant Proc; 2005 Dec; 37(10):4173-5. PubMed ID: 16387070
    [Abstract] [Full Text] [Related]

  • 4. [Change in the serologic markers of hepatitis B after allogenic hematopoietic stem-cell transplantation].
    Woo SY, Cho SH, Lee SM, Koh MB, Noh CH, Kim CW, Choi JY, Yang JM, Han JY, Lee YS.
    Korean J Hepatol; 2009 Jun; 15(2):131-9. PubMed ID: 19581765
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. [Hepatitis B virus reactivation in patients with HBs antibodies after allogeneic hematopoietic stem cell transplantation].
    Fujimaki K, Nakaseko C, Oshima K, Sakai M, Chou R, Kanda Y, Nishimura M, Kanamori H, Sakamaki H.
    Rinsho Ketsueki; 2007 May; 48(5):386-90. PubMed ID: 17571583
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Hepatitis B surface antigen (HBsAg) infection in a hemodialysis unit. II. Factors affecting host immune response to HBsAg.
    Sengar DP, Rashid A, McLeish WA, Harris JE, Couture RA, Sutherland M.
    Can Med Assoc J; 1975 Nov 22; 113(10):945-8. PubMed ID: 1104126
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. HBsAg as predictor of outcome in renal transplant patients.
    Ridruejo E, Brunet Mdel R, Cusumano A, Diaz C, Michel MD, Jost L, Jost L, Mando OG, Vilches A.
    Medicina (B Aires); 2004 Nov 22; 64(5):429-32. PubMed ID: 15560544
    [Abstract] [Full Text] [Related]

  • 15. Immunoregulation of the in vitro anti-HBs antibody synthesis in chronic HBsAg carriers and in recently boosted anti-hepatitis B vaccine recipients.
    Barnaba V, Valesini G, Levrero M, Zaccari C, Van Dyke A, Falco M, Musca A, Balsano F.
    Clin Exp Immunol; 1985 May 22; 60(2):259-66. PubMed ID: 3874020
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. De novo hepatitis B after liver transplantation from hepatitis B core antibody-positive donors in an area with high prevalence of anti-HBc positivity in the donor population.
    Prieto M, Gómez MD, Berenguer M, Córdoba J, Rayón JM, Pastor M, García-Herola A, Nicolás D, Carrasco D, Orbis JF, Mir J, Berenguer J.
    Liver Transpl; 2001 Jan 22; 7(1):51-8. PubMed ID: 11150423
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.